Skip to content

A study in healthy men to learn about how the body absorbs, processes, and removes radioactively labeled BAY 3283142

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-510765-42-00
Acronym
22127
Enrollment
8
Registered
2024-07-25
Start date
2024-10-01
Completion date
2024-11-07
Last updated
2024-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease

Interventions

None listed

Sponsors

Bayer AG
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
Male
Age
18 Years to 64 Years

Countries

Netherlands

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026